Insider Transactions and Holdings
-
Entity Type
-
Individual
-
Role
-
Chief Commercial Officer
-
Issuer Symbol
-
TXG on Nasdaq
There are no Buy or Sell transactions made by James Wilbur since 05 Feb 2025
Holdings reported by James Wilbur for 10x Genomics, Inc.
| Security |
Num Shares |
Value |
Price $ |
Transaction Date |
Ownership |
Underlying Class |
Underlying Amount |
| Class A Common Stock |
83,342 |
$3,804,287 |
$45.65 |
22 Nov 2023 |
Direct |
|
|
| Stock Option (right to buy) |
14,555 |
|
|
21 Mar 2023 |
Direct |
Class A Common Stock |
|
| Performance-based Restricted Stock Units |
7,278 |
|
|
21 Mar 2023 |
Direct |
Class A Common Stock |
|
Transactions reported by James Wilbur for 10x Genomics, Inc.
| Sym |
Class |
Transaction |
% |
Value $ |
* Price $ |
Shares |
Shares After |
Date |
Ownership |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.